Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Central precocious puberty].

R J Odink, S L Drop

    Tijdschrift Voor Kindergeneeskunde
    |December 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Precocious puberty causes significant stress for children and families. New treatments using gonadotropin-releasing hormone (GnRH) analogs offer a promising approach for central precocious puberty.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.

    The Journal of clinical endocrinology and metabolism·2015
    Same author

    New insights into factors influencing adult height in short SGA children: Results of a large multicentre growth hormone trial.

    Clinical endocrinology·2014
    Same author

    Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects.

    The Journal of clinical endocrinology and metabolism·2013
    Same author

    Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.

    Singapore medical journal·2011
    Same author

    Tumor risk in disorders of sex development.

    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation·2010
    Same author

    High-dose GH treatment limited to the prepubertal period in young children with idiopathic short stature does not increase adult height.

    European journal of endocrinology·2010
    Same journal

    Tijdschrift voor kindergeneeskunde·2020
    Same journal

    Tijdschrift voor kindergeneeskunde·2020
    Same journal

    Tijdschrift voor kindergeneeskunde·2020
    Same journal

    [The prematurely born child; should it be as early as possible?].

    Tijdschrift voor kindergeneeskunde·1993
    Same journal

    [How do we continue?].

    Tijdschrift voor kindergeneeskunde·1993
    Same journal

    [Child nutrition: what can still go wrong in the year 1992?].

    Tijdschrift voor kindergeneeskunde·1993
    See all related articles

    Area of Science:

    • Pediatric Endocrinology
    • Reproductive Medicine
    • Hormone Therapy

    Context:

    • Precocious puberty presents significant psychosocial challenges for affected children and their families.
    • Accurate diagnosis is crucial for effective management and intervention.
    • Existing treatment protocols require careful consideration of patient well-being.

    Purpose:

    • To outline the diagnostic evaluation process for precocious puberty.
    • To introduce gonadotropin-releasing hormone (GnRH) analogs as a novel therapeutic option.
    • To discuss the implications of GnRH analog treatment for central precocious puberty.

    Summary:

    • This review covers the diagnostic evaluation of precocious puberty, emphasizing its impact on patients and their environment.

    Related Experiment Videos

  • It highlights the emerging role of gonadotropin-releasing hormone (GnRH) analogs in managing central precocious puberty.
  • The discussion focuses on the potential benefits and application of these analogs in clinical practice.

    • Impact:

    • Provides clinicians with an updated overview of precocious puberty diagnosis and management.
    • Introduces GnRH analogs as a key advancement in treating central precocious puberty.
    • Aims to improve patient outcomes and reduce the long-term effects of early puberty.